Colorectal cancer is the third leading cause of cancer-related deaths in women and men in the United States. While it is curable with early detection, it is not always possible to predict the early signs of the disease. The best advice is to undergo a regular colonoscopy to catch any potential issues before they spread and become worse. The Investigative Clinical Research group in Annapolis is leading colorectal cancer research and hopes to find a cure for it.
Surgical removal of the cancer is the standard treatment, but other treatment options may be available. While rectal cancer has a poorer prognosis and risk of recurrence, advanced treatment can greatly improve patients’ quality of life. Researchers are currently testing new treatments and researching new methods to improve patient care. The most promising of these are the early-stage clinical trials. The Center also offers a number of promising clinical trials.
The National Institutes of Health (NIH) supports research into colon, rectal, and esophageal cancer. These researchers work to develop new diagnostic tools and treatments for patients with colorectal cancer. In addition, the Memorial Sloan Kettering Cancer Center runs a registry for hereditary colorectal cancer syndromes, which helps scientists learn more about the genetic causes of colorectal diseases so they can develop new colorectal cancer treatments.
The National Cancer Institute funds research for detection, prevention, and treatment of colorectal cancer. The NCI provides funding for both basic and clinical studies and has many centers around the world where they conduct their experiments. Their staff is continually exploring new ways to detect and treat colorectal cancer. One of the newest treatment methods for colon and rectal cancer treatment involves invasive surgery through the anus.
The goal of the Colon Cancer Family Registry at the Mayo Clinic is to increase early cancer detection. The registry is a unique mix of colorectal cancer patients and their families. Over 2,000 individuals with Lynch syndrome have been identified. The registry’s goal is to improve the survival rates for people affected by colorectal cancer. The NCI has also funded Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes. These studies are designed to increase the chance of early diagnosis and treatment of patients with colorectal cancer and other adenocarcinomas.
The Investigative Clinical Research Group can focus on finding treatments specifically for you and others with colon-rectal cancer. For more information or if you have an interest in participating in a clinical trial, please visit www.icrmd.com.